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Bactericidal Activity of N-Chlorotaurine against Biofilm-Forming
Bacteria Grown on Metal Disks
Débora C. Coraça-Huber,a Christoph G. Ammann,a Manfred Fille,b Johann Hausdorfer,b Michael Nogler,a Markus Naglb
Experimental Orthopedics, Innsbruck Medical University, Innsbruck, Austriaa; Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical
Microbiology, Innsbruck Medical University, Innsbruck, Austriab
Many orthopedic surgeons consider surgical irrigation and debridement with prosthesis retention as a treatment option for
postoperative infections. Usually, saline solution with no added antimicrobial agent is used for irrigation. We investigated the
activity ofN-chlorotaurine (NCT) against various biofilm-forming bacteria in vitro and thereby gained significant information
on its usability as a soluble and well-tolerated active chlorine compound in orthopedic surgery. Biofilms of Staphylococcus au-
reuswere grown onmetal alloy disks and in polystyrene dishes for 48 h. Subsequently, they were incubated for 15 min to 7 h in
buffered solutions containing therapeutically applicable concentrations of NCT (1%, 0.5%, and 0.1%; 5.5 to 55 mM) at 37°C.
NCT inactivated the biofilm in a time- and dose-dependent manner. Scanning electronmicroscopy revealed disturbance of the
biofilm architecture by rupture of the extracellular matrix. Assays with reduction of carboxanilide (XTT) showed inhibition of
the metabolism of the bacteria in biofilms. Quantitative cultures confirmed killing of S. aureus, Staphylococcus epidermidis, and
Pseudomonas aeruginosa biofilms on metal alloy disks by NCT. Clinical isolates were slightly more resistant than ATCC type
strains, but counts of CFU were reduced at least 10-fold by 1%NCTwithin 15 min in all cases. NCT showedmicrobicidal activity
against various bacterial strains in biofilms.Whether this can be transferred to the clinical situation should be the aim of future
studies.
Metals are widely used in biomedical devices such as dentaland orthopedic implants. For example, titanium alloys and
metal-on-metal bearings are becoming more popular in total hip
arthroplasties. However, they can be colonized by bacteria,mainly
Staphylococcus epidermidis and Staphylococcus aureus, leading to
implant-related infections (1). These species can formbiofilms, an
organized and long-lived colony formwell protected from fluctu-
ations in nutrition and immune attack. Further, bacteria in bio-
films are highly resistant to antibiotics (2). A chronic peripros-
thetic joint infection can be fatal to the patient, and prolonged
stays in the hospital and consecutive surgeries can cause a major
financial burden.
A remedy against biofilms resulting from surgery-related in-
fections is highly desirable. A substance of interest isN-chlorotau-
rine (NCT), the main representative of long-lived oxidants pro-
duced by human granulocytes and monocytes (3). It can be
synthesized chemically (4) and displays broad-spectrummicrobi-
cidal properties against bacteria, viruses, fungi, and protozoa (5).
Despite that, its oxidative reactivity is mild and its tolerability
upon topical application to skin, eye, and body cavities, such as the
urinary bladder and joints, is high (5–7; M. Nagl, unpublished
data). Previous studies on its antimicrobial activity have been per-
formed against planktonic forms of bacteria (8–10), and very re-
cently, the first study on its activity against biofilm formation of
Pseudomonas aeruginosawas published (11).Micromolar concen-
trations of NCT and its analogN-bromotaurine inhibited the for-
mation of the biofilm but were not active against a mature biofilm
(11).However,N,N-dichlorodimethyltaurine (0.1% to 0.5%), an-
other analog, was active against S. aureus biofilm in the frontal
sinus of sheep (12).
Since NCT can be considered as an irrigation substance during
joint replacement surgeries, it was of interest to know if its milli-
molar concentrations, which are applied clinically, kill bacteria in
biofilms. Furthermore, the aim of this study was to investigate in
vitro its activity against biofilms on titanium alloy material used
for implants in orthopedic surgery.
MATERIALS AND METHODS
Bacterial strains. S. aureusATCC 29213, S. epidermidisATCC 12228, and
P. aeruginosa ATCC 27853 were grown overnight at 37°C on Mueller-
Hinton (MH) agar plates (Sigma-Aldrich, Hamburg, Germany). Discrete
colonies were suspended in MH broth to a McFarland turbidity of 0.5
(1.5  108 bacteria/ml). Clinical strains of S. aureus and S. epidermidis
(extricated from an excised graft by sonication) and P. aeruginosa (from
sputum) were grown as described above.
N-Chlorotaurine. Pure NCT was prepared as crystalline sodium salt
(Cl-HN-CH2-CH2-SO3Na; molecular weight, 181.57 [4]) and dissolved
in 0.1 M phosphate buffer (pH 7.1).
Biofilm formation and scanning electron microscopy (SEM). Tita-
nium alloy (TiMo12Zr6Fe2 [TMZF]) disks (disk area, 157 mm
2; Stryker
GmbH & Co KG, Duisburg, Germany) were cleaned with soap, washed
with 75% ethanol, and then autoclaved. Sterile disks were placed in 15-ml
Falcon tubes (Becton Dickinson) containing 2 ml MH broth inoculated
with 2  105 CFU/ml of the corresponding bacterial strain. The tubes
were incubated at 37°C for 48 h on a shaker. Subsequently, the disks were
rinsed in saline solution for 1 min to discard planktonic cells, added to
tubes containing 0.1% or 0.5% NCT solution, and incubated at 37°C for
1 h, 5 h, and 7 h. Negative controls in phosphate-buffered saline (PBS)
were performed in parallel.
Biofilm-covered TMZF disks treated with NCT or buffer were rinsed
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in saline solution for 1 min. They were fixed with 2.5% glutaraldehyde
(BioChemika Fluka, Buchs, Switzerland) in 0.1 M phosphate buffer (pH
7.4). After a brief wash in phosphate buffer, followed by postfixation for 1
h with 1% aqueous osmium tetroxide (ReagentPlus; Sigma-Aldrich,
Hamburg, Germany), the samples were gradually dehydrated with etha-
nol. After critical-point drying (critical-point drier [CPD] 030; Bal-Tec),
the specimens were mounted on aluminum stubs with a double-sided
adhesive tape, sputter coated with 10-nmAu/Pd (Bal-Tec), and examined
with a field emission scanning electron microscope (Gemini 982; Zeiss,
Goettingen, Germany). Magnification was set to 10,000 to examine the
biofilm as a multicellular organization and to 20,000 to investigate at a
single-cell level.
Metabolic turnover (XTT test).To investigate theNCT-mediated im-
pact on bacterial metabolism in biofilms, we applied theXTT assay (Sigma-
Aldrich, Hamburg, Germany), measuring the reduction of 2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide to the
orange formazan product. Biofilms were grown at 37°C in polystyrene
dishes of a 96-well plate and washed with PBS. They were treated at 37°C
with 3 different concentrations of NCT (0.1%, 0.5%, and 1%) for 15min,
30 min, 1 h, or 3 h each. Subsequently, they were washed twice with PBS,
XTT was added, and the plates were incubated at 37°C in the dark for 2 h.
The supernatants were transferred to fresh 96-well plates, and the absor-
bance wasmeasured at 450 nm. All values were calculated as percentage of
the negative control (PBS).
Quantitative killing tests on metal alloy disks. Biofilm-covered
TMZF disks, prepared as described above, were added to tubes containing
0.1%, 0.5%, or 1% NCT solution and incubated at 37°C for 15 min, 30
min, 1 h, or 3 h. Negative controls in phosphate-buffered saline (PBS) and
positive controls in 0.2% chlorhexidine (Sigma-Aldrich, Hamburg, Ger-
many) were performed in parallel.
After each interval, disks were sonicated for 1 min in an ultrasound
water bath (40 kHz; BactoSonic; Bandelin Electronic, Berlin, Germany) to
detach the remaining live bacteria from the disk. Subsequently, 10-l
aliquots of these solutions were spread on Mueller-Hinton agar plates
with a sterile inoculation loop, undiluted and after 10-fold and 100-fold
dilution in saline, leading to a detection limit of 100 CFU/ml. NCT was
inactivated on the plates within 3 min by reaction with the agar compo-
nents, as verified by addition of potassium iodide in separate experiments.
Plates were incubated at 37°C, and CFU were counted after 24 and 48 h.
Statistical analysis.All experiments were performed independently at
least three times. One-way analysis of variance (ANOVA) and Dunnett’s
multiple comparison test were applied for calculations using GraphPad
Prism 5 software. P values of 0.05 were considered statistically signifi-
cant.
RESULTS
Visual characterization of NCT-mediated effects on S. aureus
biofilms grown on metal disks by SEM. Scanning electron mi-
croscopy (SEM) revealed several biofilm areas distributed on the
surface of the disks treated with phosphate buffer. Amorphous
material covering the bacteria like a film can be observed in these
areas (Fig. 1A). In contrast, SEM images of biofilms after 1 h of
incubation with 0.1% NCT showed disturbances of the biofilm
architecture, absence of covering amorphous material, and an in-
crease in the size of bacteria (Fig. 1B). On disks incubated for 5 h
with 0.5%NCT, granule-like elements and total eradication of the
extracellular matrix were observed (Fig. 1C). On disks incubated
for 7 h with 0.5% NCT, only amorphous bacteria lying on the
metal surface and no intact biofilms were found (Fig. 1D).
Effects of NCT on the metabolic turnover of S. aureus orga-
nized in biofilmonmetal disks.Themetabolic turnover rate after
incubation with 3 different concentrations of NCT (0.1%, 0.5%,
and 1%) at 4 different time points ranging from 15min to 3 h was
measured by a standard XTT assay. All concentrations of NCT
significantly reduced the metabolic turnover. While 1%NCT and
0.2% chlorhexidine reached similarly high values already after 15
FIG 1 Disruption of biofilm by NCT. S. aureus biofilms were formed on a TMZF surface, incubated for 1 h with buffer solution (magnification,10,000) (A),
1 h with 0.1% NCT (magnification,20,000) (B), 5 h with 0.5% NCT (magnification,2,000) (C), and 7 h with 0.5% NCT (magnification,10,000) (D).
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min, the lowerNCT concentrations showed a reduction of 30% to
60% after 15 min and between 60 and 80% after 30 min (Fig. 2,
left). The clinical S. aureus strain showed higher resistance with a
maximum inhibition of 75% for both 1% NCT and 0.2% chlo-
rhexidine. A dependence on time and concentrationwas observed
for 0.1% and 0.5% NCT (Fig. 2, right).
Killing activity of NCT against S. aureus, S. epidermidis, and
P. aeruginosa organized in biofilms on metal disks. Next, we
sought to test for the actual killing of bacteria in the biofilm, since
that is the ultimate goal of antimicrobial treatment ofmetal grafts.
All tested bacterial strains were completely inactivated after 15
min by 0.2% chlorhexidine, the positive-control agent, while no
killing and, after 3 h, even some growth could be detected using
PBS as the negative control (Fig. 3). With NCT, we found signifi-
cant killing of all strains in a time- and dose-dependent manner.
All species were reduced by at least 1 log10 within 15 min by 1%
NCT (P 0.01). The detection limit of 2 log10 was reached after 1
h with staphylococci (3 h with the S. epidermidis clinical isolate)
and already after 30 min with P. aeruginosa (Fig. 3). The lower
concentrations of 0.5% and 0.1% NCT showed a delayed effect.
However, the 0.5% NCT solution still eradicated the biofilm after
3 h at the latest, and 0.1% induced significant killing of all test
strains at this time. In biofilm, P. aeruginosawas inactivated by 1%
NCT within 15 min (by 0.5% NCT within 30 min) and therefore
appeared to be more susceptible to NCT than were staphylococci
(Fig. 3).
Notably, the biofilms formed by clinical isolates contained a
significantly higher CFU count by 1 log10 compared to the ATCC
strains (P 0.01) (Fig. 3). Eradication of viable counts by 1% and
0.5%NCT needed more time for clinical isolates of S. epidermidis
and P. aeruginosa than for the ATCC strains (P  0.01; Fig. 3,
middle and bottom).
DISCUSSION
Titanium disks incubated with medium containing S. aureus, S.
epidermidis, or P. aeruginosa proved to be a useful in vitro model
for testing the active chlorine compound NCT against bacterial
biofilms. The chosenmetal alloys aremajor components of ortho-
pedic implants (13), and the bacterial strains used are mainly re-
sponsible for implant-associated infections (14, 15). A biofilmwas
established by all tested bacteria within 48 h on the titanium alloy
disks.
As can be derived from electronmicroscopy, NCT disrupts the
biofilm matrix, which ultimately leads to detachment of the bio-
FIG 2 XTTmetabolic turnover assay. S. aureus ATCC 29213 (left) and clinical strain (right) biofilms were grown for 48 h and then incubated with 1% (circles),
0.5% (squares), and 0.1% (triangles)NCT for 15min, 30min, 1 h, and 3 h. PBS (diamonds) and 0.2%chlorhexidine (CHX) (inverted triangles) served as negative
and positive controls, respectively. Metabolic turnover was measured by standard XTT assay. Mean values  standard deviations of three independent
experiments. Pwas0.01 forNCT and chlorhexidine versus PBS at all incubation times; Pwas0.01 between chlorhexidine and 0.1% and 0.5%NCT at 15min;
P was0.05 between chlorhexidine and 1% NCT at all incubation times; these values apply to both strains.
FIG 3 Killing of S. aureus by NCT. Biofilms of S. aureus ATCC 29213, an S.
aureus clinical isolate, S. epidermidis ATCC 12228, an S. epidermidis clinical
isolate, P. aeruginosa ATCC 27853, and a P. aeruginosa clinical isolate were
grown on metal alloy disks for 48 h. Subsequently, disks were incubated with
1%, 0.5%, and 0.1% NCT for 15 min, 30 min, 1 h, and 3 h. PBS and 0.2%
chlorhexidine (CHX) served as negative and positive controls, respectively.
Surviving bacteria were detached by sonication, and 10-l samples of the so-
lution were spread on fresh agar plates. Mean values standard deviations of
three independent experiments. P was0.01 for all reductions in CFU com-
pared to the PBS control; P was 0.01 between all NCT concentrations and
0.2% chlorhexidine, except for 1% NCT in P. aeruginosa ATCC 27853.
N-Chlorotaurine against Biofilms
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film.We visualized the disruption of the extracellular matrix dur-
ing a 7-h course using a 0.5%NCT solution. On a single-cell basis,
we observed swelling of bacteria early during treatment (Fig. 1B).
This could be due to osmotic effects after membrane destabiliza-
tion by NCT. After 5 h, no more extracellular matrix could be
detected, and subsequently, bacteria were detached from the sur-
face (Fig. 1C and D). Transferred to the in vivo situation, removal
of biofilms from prosthetic material could render bacteria acces-
sible to the defense system, which may lead to an immune re-
sponse against germs not immediately killed by NCT. Adherence
of bacteria to surfaces is mediated by proteins in S. aureus (16), S.
epidermidis (2), and P. aeruginosa (17). Since NCT and analog
substances recently have been shown to directly inactivate bacte-
rial toxins (8, 18), it seems likely that the detachment of biofilms
by NCT is due to an impact on these adherence proteins via oxi-
dation of thiols and aromatic and amino groups (4, 5). To clarify
the exact molecular sites of attack could be an interesting item in
future studies.
In a recent study, low concentrations of NCT (300 and 1,000
M) inhibited the P. aeruginosa biofilm formation but did not
destroy the biofilm or kill hidden bacteria (11). Inmillimolar con-
centrations, however, we found a time- and concentration-depen-
dent antibiofilm activity at concentrations between 0.1% and 1%
(5.5 to 55 mM). Of note, 1% NCT, an approximately 1,000-fold
excess over the physiological concentration (19), can be applied
clinically to different body regions and cavities (for a review, see
reference 5). Its bactericidal activity against S. aureus and S. epi-
dermidis in biofilm (reduction of CFU to the detection limit by 1%
NCTneeded about 30 to 60min [Fig. 3]) appears approximately 3
to 6 times slower than that against planktonic bacteria (10min for
a reduction to the detection limit [9, 10]) but is still sufficient.
Remarkably, viable counts of all tested bacteria in biofilm were
reduced by at least 1 power of 10 after 15 min of incubation in 1%
NCT, so that an impact on biofilm by irrigations with NCT can be
conceived in vivo. This remains to be confirmed in future clinical
studies.
The absence of the antimicrobial activity of micromolar NCT
against P. aeruginosa biofilm in the recent study (11) might be
explained by consumption of oxidative capacity by reducingmoi-
eties of the proteinaceous matrix of the biofilm (chlorine con-
sumption [4, 5]). However, the mild activity and high tolerability
of N-chloro amino acids, particularly NCT, enable application of
high concentrations to human tissue, which warrants a sufficient
reserve of oxidation capacity despite some reduction (20). This
can be of advantage compared with highly reactive oxidants
that cause side effects at higher dosages (21). Accordingly, NCT
was shown to be effective in topical therapy of infections where
biofilms play a role, for instance, purulently coated crural ul-
cerations and external otitis in humans (22, 23) and joint in-
fections in mice (7).
Comparing quantitative killing assays with metabolism (XTT
tests), the expected result became obvious, i.e., that the bacterial
metabolism is affected within minutes and therefore earlier than
viability. Remarkably, as in killing tests, the clinical strains showed
a slightly lower susceptibility to NCT than did the ATCC strains.
In agreement with previous findings (24), clinical isolates formed
a thicker biofilm with 10-fold-higher CFU counts, which obvi-
ously explains their higher resistance.
Weused chlorhexidine as a positive control since it is one of the
most widely used antiseptics on skin and mucous membranes
(25). In agreement with previous studies (26, 27), we found activ-
ity of 0.2% chlorhexidine against our test strains in biofilm, so that
it turned out to be a good positive control. Although the activity of
NCT was lower than that of chlorhexidine, it has distinct advan-
tages. NCT is an endogenous substance with mild activity con-
nected with a very good tolerability even in highly sensitive body
regions, an advantage compared to antiseptics (for a review, see
references 5 and 21). As it is an active chlorine compound, the
microbicidal spectrum is very broad without development of re-
sistance, an advantage compared to antibiotics (5).
Use of antibiotics can further lead to development of bacterial
persister cells, which are not growing and thus remain unaffected
in the presence of antibiotics (28). However, these bacteria can
regenerate and reestablish infection after termination of the anti-
biotic treatment. NCT completely eradicated the biofilm in our
study, so it can be concluded that it kills bacteria independently of
protein production, cell cycle, or proliferation. This is in accor-
dance with its oxidative mechanism of action (5, 21) and with its
efficacy in treatment of infections of different body sites in hu-
mans (for a review, see reference 5). For instance, successful ap-
plication was demonstrated in purulently coated crural ulcer-
ations and in external otitis in humans (22, 23). Based on these
findings, we speculate that the substance could be effective also for
irrigation of orthopedic joint implants in case of infection or for
prophylaxis of infections, supported by the following arguments.
There was a significant reduction of CFU by at least 1 log10 within
15 min in biofilms by 1% (55 mM) NCT (Fig. 2 and 3), the con-
centration used clinically in most indications (5). The contact
time of NCT in vivo can be prolonged, for instance, by extended
irrigation periods (22) or by clamping catheters (29). Moreover,
in the mouse peritonitis model it has been shown that short, sub-
lethal times of incubation in NCT (1 min for the 1% concentra-
tion) are connected with a lag of regrowth and loss of virulence of
bacteria (30). Tolerability upon joint irrigation and efficacy in
joint infections and collagen-induced arthritis have already been
shown in mouse models (7, 19, 31, 32). Nevertheless, double-
blind randomized clinical trials will be needed to demonstrate the
efficacy of NCT in orthopedic infections in humans.
NCT in millimolar concentrations can efficiently kill bacteria
in an active and established biofilm in vitro. It seems a promising
task for future studies to determine whether NCT can be used in a
clinical setting to combat bacterial colonization and biofilm for-
mation in prosthetic joint surgery as well as to fight already-estab-
lished infections.
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